FDA greenlights GSK’s drug for UTIs in women and girls
The FDA approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new ...
Fierce Pharma11h
GSK ushers in new UTI antibiotic with FDA nod for first-in-class Blujepa
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
US FDA approves GSK's 'Blujepa' for treating UTIs in women and girls
The approval was based on data from two late-stage trials showing the drug was superior to nitrofurantoin, the ...
US FDA approves GSK's urinary tract infection drug
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
US FDA greenlights GSK's drug for UTIs in women and girls
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
The Cardiology Advisor16h
RSV Linked to High Burden of Hospitalizations Prior to Vaccine Availability
Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.
The Lancet1d
Early impact of RSV vaccination in older adults in England
Population-based analyses of new vaccination programmes provide robust real-world evidence for post-licensure vaccine ...
Fierce Pharma1d
Gavi terminates COVID vaccine deal with Clover, demands $224M repayment
Novavax reached a settlement with Gavi, the Vaccine Alliance, after t | International vaccine partnership Gavi has ...
Medscape1d
Bivalent RSV Vaccine Shows Sustained Efficacy and Safety Through Two Seasons in Older Adults
The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...
Vietnam Investment Review on MSN1d
Clover Announces U S IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB 1019
U.S. IND clearance and revaccination trial initiation supports the differentiated global opportunity for Clover's RSV PreF vaccine (SCB-1019) utilizing validated Trimer-Tag platform -- -- Evaluation ...
Should I buy GSK shares at £15?
GSK shares are trading cheaply and offering potential passive income. So is this FTSE 100 stock a no-brainer buy for my ...
Pfizer has a new playbook for reviving sales—and it’s starting to pay off
The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...